Main
>
ONCOLOGY (**)
>
Lung>NSCLC>MET>PD-L1+>> ***
>
Treatment
>
CH. R. AtezolizuMAb ***
>
(*) USA Approval Date: 2016. 10.18.
(*) USA Approval Date: 2016. 10.18.'s products
This section has no products